| Term 
 | Definition 
 
        | host organism's response to a pathogen, or a disease-causing substance   occures when tissue-destroying microorganisms enter & multiply in the body   to cause disease, microbial pathogens must adhere to cell surface, colonize & invade the host and proliferate inside  |  | 
        |  | 
        
        | Term 
 
        | some infections take the form of minor illnesses, others result in a life-threatening condition called ____, causing widespread vasodilation and multiorgan system failure (shock) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | severe condition in which infection has spread into the  blood |  | 
        |  | 
        
        | Term 
 
        | infection-causing microbes (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | microscopic genetic parasites that contain genetic material (DNA or RNA) but have no metabolic capability & need a host cell to replicate   (no cell walls, membranes, etc)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | single-celled microorganisms that have no true nucleus & reproduce by cell division   pathogenic bacteria contain cell-damaging proteins that cause infection; these proteins come in two forms:    exotoxins endotoxins  |  | 
        |  | 
        
        | Term 
 
        | cell damaging proteins contained in pathogenic bacteria:   exotoxins  |  | Definition 
 
        | released during cell growth |  | 
        |  | 
        
        | Term 
 
        | cell-damaging proteins in pathogenic bacteria that cause infection:   endotoxins  |  | Definition 
 
        | released when the bacterial cell wall decomposes; they cause fever & are not affected by antibiotics (can be dangerous to the host) |  | 
        |  | 
        
        | Term 
 
        | bacteria are classifed by several different ways: |  | Definition 
 
        | by shape, growth requirements, motility & whether they are aerobic (requiring oxygen) or anaerobic |  | 
        |  | 
        
        | Term 
 
        | gram-positive bacteria   2 examples?  |  | Definition 
 
        | these are everywhere; everything going on in the community   streptococcal organisms staphylococcal organisms   (gram-positive rods are not commonly seen)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | encountered at the hospital   include gram-negative rods and cocci & gram-negative obligate intracellular parasites  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | no cell wall   include mycoplasma and chlamydia  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonphotosynthetic microorganisms that reproduce asexually (by division) & contain a true nucleus |  | 
        |  | 
        
        | Term 
 
        | 2 classifications of fungi |  | Definition 
 
        | yeast: round, single celled facultative anaerobes that can live with or without oxygen   molds: filament-like, mutinucleated, aerobic microorganisms   mycotic infections: infections caused  by fungi; pathogenic fungi release mycotoxins 
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | single-celled or multicelled organisms that depend on a host for food & a protective environment   most common parasitic infections, such as tapeworm infestation, occur in the intestines  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | agents (natural, synthetic, semi-synthetic) which kill or inhibit growth of microorganisms (pathogens) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | substances produced by certain organisms which kill or inhibit the growth of other microorganisms   subset of antimicrobials   sulfa drugs: only ones that come from the lab  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ability to kill an invading microorganism w/o harming the cells of the host    possibly b/c microbial pathogens difer in cellular structures or biochemical processes from human hosts   this is the most important quality aside from effectiveness  |  | 
        |  | 
        
        | Term 
 
        | classification of antimicrobial agents |  | Definition 
 
        | bactericidal-bacteriostatic actions   site of action/mechanisms of action  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | arrest the growth & replication of bacteria, thus giving the body's immune system a chance to destroy & remove the pathogens   depend on the host having an intact immune status (so immune system can finish the job)   cannot be used in life-threatening situations; too slow to act   e.g. erythromycin, tetracyclines, sulfonamides  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drugs that kill microorganisms   less dependent on the host's defense mechanisms for their therapeutic effects (so, drug of choice for HIV pts, etc)   e.g. beta-lactam antibiotics, penicillins, vancomycin  |  | 
        |  | 
        
        | Term 
 
        | bactericidal agents are preferred in tx of _____ |  | Definition 
 
        | serious, life-threatening infections and/or when the host's immune system is not functioning properly |  | 
        |  | 
        
        | Term 
 
        | some antimicrobial drugs may exert either a bactericidal or a bacteriostatic action depending on ____ |  | Definition 
 
        | the dose used   causative organism being acted upon   site of action of the drug  |  | 
        |  | 
        
        | Term 
 
        | site of action/mechanisms of action   4 categories  |  | Definition 
 
        | inhibitors of bacterial cell wall synthesis   inhibitors of  bacterial protein synthesis   inhibitors of bacterial metabolism (nucleic acid synthesis, energy metabolism)   disruptors of cell membrane permeability  |  | 
        |  | 
        
        | Term 
 
        | inhibitors of bacterial cell wall synthesis |  | Definition 
 
        | bactericidal   effective on "growing" bacteria that synthesize a peptidoglycan cell wall; should not be combined w/ bacteriostatic drugs     also inactive against organisms devoid of this structure (fungi, viruses, etc)   selectively interfere w/ the synthesis of the bacterial cell wall   bacterial cell walls are thicker & more rigid than the membranes of mammalian cells; they contain complex macromolecules that are formed via biosynthetic pathways which are absent from mammalian cells   block the cross-linking of peptidoglycan chains, which is the final step in bacterial cell wall synthesis, thereby producing deficiencies in the cell walls; interior of the cell is hypertonic, H20 enters the interior of the cell & causes lysis  |  | 
        |  | 
        
        | Term 
 
        | inhibitors of bacterial cell wall synthesis   examples:  |  | Definition 
 
        | penicillins, cephalosporins, monobactams, carbapenems, bacitracin (topical), vancomycin |  | 
        |  | 
        
        | Term 
 
        | disruptors of cell membrane permeability |  | Definition 
 
        | increase the permeability of the bacterial cell membrane thereby permitting leakage of intracellular components to take place   differing ratios btwn sterol & phospholipid contents in mammalian & microbial cell membrane appear to be the basis  for the selectivity of these agents   considered bactericidal in their action since interference w/ the cell membrane results in the immediate death of microbes  |  | 
        |  | 
        
        | Term 
 
        | disruptors of cell membrane permeability   examples:  |  | Definition 
 
        | amphothericin B, imidazoles, polymixins |  | 
        |  | 
        
        | Term 
 
        | inhibitors of bacterial protein synthesis |  | Definition 
 
        | affect bacterial protein synthesis w/ relative selectivity   target the bacterial ribosome (smaller than the mammalian ribosome)   mammalian mitochondrial ribosome more closely resembles the bacterial chromosome; although drugs usually spare the host cells, high levels of drugs may cause toxic effects as a result of interaction w/ the mitochondrial ribosomes (relative selectivity)  |  | 
        |  | 
        
        | Term 
 
        | inhibitors of bacterial protein synthesis    examples:  |  | Definition 
 
        | aminoglycosides (cidal), tetracyclines, macrolytes, clindamycin, chloramphenicol, streptogamin |  | 
        |  | 
        
        | Term 
 
        | inhibitors of bacterial metabolism |  | Definition 
 
        | nucleic acid synthesis inhibitors of nucleic acid synthesis; bactericidal (quinolones, fluoroquinolones)   foliate antagonists inhibit folic acid synth; in the absence of folic acid, cells cannot grow or divide (folic acid coenzynes are required for the synth of purines & pyrimidines - precursors of RNA/DNA)   humans obtain folate in the diet, but many microorganisms must synthesize this substance by using PABA as substrate   function as competitive analogues of PABA   bacteriostatic alone & bactericidal in combo   (sulfonamides, trimethaprim, bactrim)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | refers to the ability of a microorganism to withstand a drug that was previously toxic to it   many orgainisms have adopted, through spontaneous mutation or acquired resistance & selection & developed more virulent stains many of which are more resistant to multiple abx   cross resistance can occur btwn antimicrobial drugs, especially if they are chemically related & have similar mechanisms of action  |  | 
        |  | 
        
        | Term 
 
        | four basic mechanisms  by which microorganisms can become resistant to abx |  | Definition 
 
        | production of drug-inactivation enzymes e.g. B-lactamases destroy many penicillins/cephalosporins   changes in drug penetration microbes may adopt to become impermeable to the abx or increase their ability to excrete the abx; aminoglycosides, tetracyclines   changes in receptor structure abx such as erythromycin bind to certain receptors; microorganisms can cause these receptors to mutate so that they have very little affinity for abx   alterations of metabolic pathways bacteria may acquire the ability to use performed folic acid, bypassing the inhibitory actions of sulfonamides   bacteria may alter the target of the abx (e.g. altered forms of the enzymes that make cell walls)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | severity ranges from a mild rash to fatal anaphylaxisone of the most common drug allergies is allergy to PCN; about 10% of users develops sensitivity to PCNsresponse may develop within 30 min of admin (anaphylaxis, laryngeal edema, shock, dyspnea, skin rxns), within few days, or may occur several days after d/c of txcross-sensitivity-hypersensitivity reaction with any drug in the same chemical classall pts must be questioned for previous allergic rxns; allergy prome pts must be observed closelyimportant not to label a pt. allergic to a perticular drug w/o adequate documentation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | high serum levels of certain abx and/or prolonged use may cause toxicity by affecting cellular processes in the host directlye.g. aminoglycosides can cause ototoxicity by interfering w/ membrane function in the hair cells of the organ of Corti
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug therapy, particularly w/ broad-spectrum antimicrobials or combo of agents can lead to alterations of the normal microbial flora of the upper respiratory, GI, GU tracts, permitting the overgrowth of opportunistic organisms (esp. fungi or resistant bacterial strains) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drugs w/ structure containing a beta-lactam ring that is essential for antimicrobial activity   include PCNs & cephalosporins   bactericidal drugs   exhibit some cross-sensitivity (i.e. PCN allergy may translate into a cephalosporin allergy 5-10% of pts)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | most widely effective & extensively used abx   among the least toxic drugs known   derived from cultures of molds or manufactured semisynthetically   natural PCNs are potent gram-pos. killers; they have little to no coverage against gram-neg. organisms  |  | 
        |  | 
        
        | Term 
 
        | pharmacodynamics of PCNs: |  | Definition 
 
        | bactericidal; interfere w/ cell wall synth. by inhibiting biosynthesis of cell wall mucopeptides   most effective on rapidly growing organisms   have virtually no untoward effec on human cells; safe in children, elderly, and during pregnancy (cat. B)   do not cross the BBB except when the meninges are inflamed  |  | 
        |  | 
        
        | Term 
 
        | Subclass of PCNs:   natural PCNs/narrow spectrum  |  | Definition 
 
        | penicillin G (prototype drug, PO/IV/IM)   penicillin V (penVeeK) (PO only, less potent)   penicillin G procaine (crysticillin A.S.) (IM only, releases PCN over period of 4-24 hrs; used for desensitizing allergic pts)   penicillin G benzathine (bicillin L-A) (IM only; long-acting repository form; produces low, but sustained blood levels of PCN for as long as 4 wks)   all natural PCNs work the same way but differ in route of  admin & stability to gastric acid   broad spectrum: gram pos organisms the most (strep, staph)-the most effective; gram neg; gram pos anerobes   susceptible to inactivation of B-lactamases (penicillinases)    |  | 
        |  | 
        
        | Term 
 
        | subclass of PCNs:   penicillinase-resistant PCNs (antistaphylococcal)  |  | Definition 
 
        | resistant to penicillinase (bacterial enzyle that hydrolyzes the amide bond of the B-lactam ring)   SPECTRUM-use restricted to the tx of infections caused by penicillinase producing staphylococci    MRSA-Methicillin Resistant Staphylococcus Aureus major source of nosocomial or community-acquired infections; usually susceptible only to vancomycin 
 |  | 
        |  | 
        
        | Term 
 
        | example of penicillinase resistant PCNs: |  | Definition 
 
        | methicillin (staphcillin) IM/IV |  | 
        |  | 
        
        | Term 
 
        | subclass of PCNs:   broad spectrum PCNs (aminopenicillins)  |  | Definition 
 
        | not resistant to penicillinase   SPECTRUM-all of the organisms affected by the natural PCNs, plus are more effective against gram-neg bacilli (salmonella, shigella, etc)    resistance to these abx is a major clinical problem b/c of inactivation by plasmoid-mediated penicillinase; frequently resistant: E.coli, H.influenzae (30-40%), M. catarrhalis (70%)   important toxicities of ampicillin: incidence of rash is extremely high in pts w/ mono; ampicillin-induced psuedomembraneous colitis is another potential side-effect   |  | 
        |  | 
        
        | Term 
 
        | examples of broad-spectrum PCNs (aminopenicillins) |  | Definition 
 
        | amoxicillin (Amoxil) PO   ampicillin (Omnipen) PO/IV/IM  |  | 
        |  | 
        
        | Term 
 
        | subclass of PCNs:   extended-spectrum PCNs (antipseudomonal)  |  | Definition 
 
        | SPECTRUM: less effective against the typical Pen G spectrum & ineffective against staphylococci; gram-neg coverage includes: pseudomonas, enterobacter, klebsiella   important in treating serious gram-neg bacteria; often used in combo w/ aminoglycosides  |  | 
        |  | 
        
        | Term 
 
        | example of extended-spectrum PCNs |  | Definition 
 
        | piperacillin (Pipracil) IV/IM |  | 
        |  | 
        
        | Term 
 
        | combinations of PCNs w/ B-lactamase inhibitors |  | Definition 
 
        | have the same specgrum as the original PCNs + coverage against penicillinase-producing bacgteria such as staph, etc.   B-lactamase inhibitors inhibit the enzyme by binding to it & thus protecting the accompanying abx; on their own, B-lactamase inhibitors are not effective in eliminating bacteria  |  | 
        |  | 
        
        | Term 
 
        | examples of combinations of PCNs + B-lactamase inhibitors |  | Definition 
 
        | amoxicillin + clavulanic acid = augmentin   piperacillin + tazobactam = zosyn  |  | 
        |  | 
        
        | Term 
 
        | contraindications of PCNs |  | Definition 
 
        | hypersensitivity & allergy   caution with severe renal insufficiency; doses should be adjusted  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hypersensitivity rxns: rarely anaphylaxis, urticaria, fever, joint swelling, bronchospasm(#1 toxicity to watch for)seizures: may occur in pts w/ poor renal function or in newborns who have immature anion transport systemsGI disturbances: diarrhea,nausea/emesis, most comme adverse effectssuperinfectionsPseudomembranous colitis: aminopenicillins & extende-spectrum PCNs-diarrhea caused by a changei nthe flora of the colon or an overgrowth of a toxin-producing strain of clostridium difficileelectrolyte imbalances: hyperkalemia & hypernatremia possible; b/c PCNs are combined w Na or K, pts may suffer from excess Na/K  (i.e. PCNs are salts) 
 |  | 
        |  | 
        
        | Term 
 
        | drug/food interactions with PCNs |  | Definition 
 
        | PROBENECID: increased serum levels of PCN by decreasing its renal elimination, thereby increasing serum PCN levels & enhancing PCHs effectiveness (so, need less dose)oral contraceptives: decreased effectivenessanticoagulants: increased risk of bleedingtetracyclines & other bacteriostatic abx: interfere w/ effectiveness of the PCNsAntacids: impair the absorption of PO PCNsaminoglycosides: chemically inactivated if mixed in a sol'n w/ PCNFood: PCN G should be taken on empty stomach w/ full glass of water (but, it's not longer given PO)fruit juices (orange) & sodas contribute to decomposition of PCNs & should be avoided w/ PO PCNs
 |  | 
        |  | 
        
        | Term 
 
        | give IM PCN injections _____ |  | Definition 
 
        | deep into large muscle mass   shake med well before injection & massage the site prior to injection   mostly unchanged drug appears in the urine  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | originate from the Cephalosporium fungichemically related to PCNs: similar mech of activity, renal excretion & allergenicitymay be used as alternatives when pts are allergic to PCNs: 5-10% cross-over sensitivityprimarily are bactericidal & act on bacteria by interfering w/ bacterial cell wall  synthesis: bacterial cell walls weaken, swell & burst from increased osmotic pressure within the cell causing bacterial cell deathwidely distributed in body fluids; some (not all) enter CNS; mostly eliminated by renal excretionresistant to penicillinases but sensitive to other B-lactamases (i.e.cephalosporinases)
 |  | 
        |  | 
        
        | Term 
 
        | cephalosporins are usually well tolerated; side effects are usually minor and include: |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | compared to PCNs, cephalosporins are less active against gram-____ organisms & more active against gram-____ organisms. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | cephalosporins are organized into four generations based on their order of  development & general features of antimicrobial activity   from 1st generation to 4th generation, there is:   (4)  |  | Definition 
 
        | decrease in gram-positive coverage   increase in gram-negative coverage   increase in CNS penetration   increase in resistance to B-lactamase  |  | 
        |  | 
        
        | Term 
 
        | first generation cephalosporins |  | Definition 
 
        | preg. category Boldest cephalosporins; all  have similar spectrum of actionpossess excellent activity against gram-pos bacteria & poor activity against gram-neg organismsspectrum: gram-pos cocci, including pneumococci, staphylococci, streptococci (group A is the strep group we worry about)enterococci & MRSA not covered
 |  | 
        |  | 
        
        | Term 
 
        | examples of first generation cephalosporins |  | Definition 
 
        | cefazolin (Ancef, Kefzol) prototype: IV/IM (most commonly used)   cephalexin (Keflex) PO (#1 PO)  |  | 
        |  | 
        
        | Term 
 
        | general clinical use of first generation cephalosporins |  | Definition 
 
        | uncomplicated, community-acquired infections of the skin & soft tissue & urinary tract (E.coli)   useful for respiratory infections caused by PCN-sensitive streptococcus pneumoniae   parenteral 1st generation agents (Ancef) are used  for surgical would prophylaxis    cefazolin (Ancef) remains the more popular parenteral "1st generation" agent due to its superior blood & tissue conc., low cost, low toxicity  |  | 
        |  | 
        
        | Term 
 
        | second-generation cephalosporins |  | Definition 
 
        | preg. category Bcover the same organismsas first-generation; less active against gram-pos but w/ increased activity against gram-neg organisms, including H. influenza, M. catarrhalis, S.pneumoniae
 |  | 
        |  | 
        
        | Term 
 
        | example of second-generation cephalosporins |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | general clinical use for second-generation cephalosporins |  | Definition 
 
        | community acquired URIs (H.influencae, M. catarrhalis, S. pneumoniae) & uncomplicated UTIs (E.coli)   useful in mixed aerobic/anaerobic infections of the skin  & soft tissue, intra-abdominal infections, gynecological infections, surgical prophylaxis  |  | 
        |  | 
        
        | Term 
 
        | third-generation cephalosporins |  | Definition 
 
        | preg. category Bprovide extended gram-neg coverage but poor gram-pos coverage (opposite of first generationa agents)ceftriaxone is one of two agents of choice for tx of meningitis (adequate CNS penetration)no activity against MRSA, enterococci, Listeria
 |  | 
        |  | 
        
        | Term 
 
        | example of third-generation cephalosporines |  | Definition 
 
        | ceftriaxone (Rocephin) IV |  | 
        |  | 
        
        | Term 
 
        | general clinical use of third-generation cephalosporins |  | Definition 
 
        | for infections involving gram-neg bacteria, particularly hospital-acquired infections or complicated community-acquired infections of the respiratory tract, blood, intra-abdominal, skin & soft tissue, urinary tract   third-generation may be an alternative to aminoglycosides, esp in some pts w/ renal dysfunction b/c of their activity against gram-neg bacteria  |  | 
        |  | 
        
        | Term 
 
        | fourth-generation cephalosporins   |  | Definition 
 
        | very expensive   possess the gram-neg coverage of the third-generation & gram pos coverage of the first-generation cephalosporins  |  | 
        |  | 
        
        | Term 
 
        | example of fourth-generation cephalosporins |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | contraindications of cephalosporins |  | Definition 
 
        | caution in hypersensitivity to PCN; however, b/c this is not always the case, can be administered but w/ caution (5-10% cross-sensitivity)caution in pts w/ history of GI or renal disease, especially those receiving diuretics
 |  | 
        |  | 
        
        | Term 
 
        | adverse effects of cephalosporins |  | Definition 
 
        | usually tolerated well and are the safest type of abx   hypersensitivity: resembles PCN allergy, most frequent side effect; occurs in 1-2% pts w/o PCN allergy; risk of allergy lower w/ PO routedisulfiram-like effect: when ingested w/ ETOH or ETOH-containing meds (become violently sick)Bleeding: may occur due to vit. K inhibition; admin of vit K corrects the problemnephrotoxicity: when used w/ other nephrotoxic drugs & in elderlypain at the IM injection site & phlebitis (vein inflammation) at the IV infusion site)arthritissuperinfections
 |  | 
        |  | 
        
        | Term 
 
        | drug interactions with cephalosporins |  | Definition 
 
        | ETOH: antabuse-like effectaminoglycosides: increased risk of nephrotoxicityaspirin: increased potential risk of bleedinganticoagulants: increased anticoagulant effectprobenecid: decreased excretion of cephalosporins & increased serum levels  
 |  | 
        |  | 
        
        | Term 
 
        | other B-lactam antibiotics:   Carbapenems  |  | Definition 
 
        | broadest spectrum B-lactam antibiotic preparation currently available (safe)resists hydrolysis by most B-lactamasesused frequently in empiric therapy since it is active against penicillinase-producing gram-pos & gram-neg organisms, anaerobes &Pseudomonas aeruginosadoes not cover MRSA, C.difficile
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | imipenem/cilastatin (Primaxin) IV/IM |  | 
        |  | 
        
        | Term 
 
        | adverse effects of carbapenems |  | Definition 
 
        | n/v/d   seizures in high doses (b/c stays as metabolite in kidney-but cilastatin helps neutralize this problem) --> so, you're safe as long as dose is right  |  | 
        |  | 
        
        | Term 
 
        | other B-lactam antibiotics:   Monobactams  |  | Definition 
 
        | not as freq. used b/c for specific bacteriaspectrum: primarily directed against enterobacteria (gram-neg rods in GI); lacks activity against gram-pos organisms & anaerobeshas low immunogenic potential & shows little cross-sensitivity w/ antibodies induced by other B-lactams, offering a safe alternatve for treating pts allergic to PCNs and/or cephalosporins
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | aztreonam (Azactam) IV/IM |  | 
        |  | 
        
        | Term 
 
        | adverse effects of monobactams |  | Definition 
 
        | relatively nontoxic/safe; may cause phlebitis, skin rash, and occasionally abnormal liver function tests |  | 
        |  | 
        
        | Term 
 
        | other agents affecting the cell wall:   vancomycin (Vancocin)  |  | Definition 
 
        | effective against all gram-pos organismspresently reserved for tx of  severe infections caused by MRSA or serious gram-pos infection in PCN-allergic pts (b/c not safe)also used to treat C.diff-induced pseudomembranous colitis & for prophylaxis in pts w/ prostatic valves who are undergoing oral surgeryadminstered IV, except when treating pseudomembranous colitis, then POadmin IV over 90+ min to avoid Red Man's Syndrome (regardless of dose)
 |  | 
        |  | 
        
        | Term 
 
        | adverse effects of vancomycin |  | Definition 
 
        | fever/chillsphlebitis at the infusion siteshock as a result of rapid admin.dose related ototoxicity & nephrotoxicity (esp in pts w/ renal failure)Red Man's Syndrome: facial flushing & hypotension due to rapid infusion, thought to be caused by histamine release; if occurs, slow admin.
 |  | 
        |  | 
        
        | Term 
 
        | other agents affecting the cell wall:   bacitracin  |  | Definition 
 
        | used against gram-pos organismsuse is restricted to topical application b/c of its potential for nephrotoxicity if given systemically
 |  | 
        |  | 
        
        | Term 
 
        | bacterial protein synthesis inhibitors:   tetracyclines  |  | Definition 
 
        | previously used  as bacteriostatic broad-spectrum abx, but not anymore b/c there is so much resistancesuppress bacterial growth by inhibiting protein synthesis; bind reversibly to the 30S ribosomal subunit, blocking the amino acid-linked RNA from attaching to the ribosome site & inhibiting the protein synth. required for maintaining the bacterial cellprimarily bacteriostatic but in higher doses may be bacteriocidalnow used for obscure infections & acne
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | tetracycline (Sumycin) - generic/cheap but short 1/2 life and must be on empty stomach (1-2 hrs after food)   doxycycline (Vibramycin)   minocycline (Minocin) - better 1/2 life  |  | 
        |  | 
        
        | Term 
 
        | pharmacotherapeutics of tetracyclines |  | Definition 
 
        | true broad-spectrum abxcurrently rarely used against gram-pos or gram-neg pathogens but used for less common, more atypical infectionsfirst line drug for Rocky Mountain spotted fever, other rickettsial infections, Lyme disease, many STDs, cholera, malaria, Traveler's diarrhea...in PCN-allergic pts used to treat certain STDs, urinary & respiratory tract infections, meningitis
 |  | 
        |  | 
        
        | Term 
 
        | contraindications of tetracyclines |  | Definition 
 
        | pts w/ renal & hepatic dysfunction & bile duct obstructioncontraindicated in pregnancy & kids before 8 yrs of age; may cause a permanent brown, yellow, or gray discoloration of teeth and may inhibit fetal skeletal growth; may cause severe hepatotoxicity during pregnancycontraindicated in hypersensitivity to any tetracycline or sulfite
 |  | 
        |  | 
        
        | Term 
 
        | adverse effects of tetracyclines |  | Definition 
 
        | photosensitivityGI: n/v are most common symptoms; these are very irritating to gastric mucosadiscolorations of both deciduous & permanent teethhepatotoxicity: high dose IV tetracycline that exceeds 2gm/day has been associated w/ liver failure & deathPhlebitis: tetracyclines are very irritating to veinshypersensitivity: anaphylaxis, exfoliative dermatitis, exacerbation of systemic lupus erythematosus, serum sickness seen as fever, rash, arthralgia
 |  | 
        |  | 
        
        | Term 
 
        | drug interactions with tetracyclines |  | Definition 
 
        | tetracyclines should be admin. 1 hr before food or 2 hrs after meals w/ a full glass of wateroral contraceptives: may decrease in effectivenesschelating agents (milk products, calcium, iron, magnesium-containing laxatives, most antacids): impaired absorption due to formation of insoluble ions; should be administered at least 2 hrs before or after any of these agentscholestyramine/colestipol: decreased PO absorption of tetracyclinesconcomitant use w/ PCN b/c bacteriostatic drugs (tetracyclines) may interfere w/ the bacterial effect of PCNcimetidine: may decrease GI absorption of tetracyclinesdigoxin: may increase levels of digoxin
 |  | 
        |  | 
        
        | Term 
 
        | bacterial protein synthesis inhibitors:   aminoglycosides  |  | Definition 
 
        | narrow spectrum bactericidal abx (for serious gram-neg infections)limited use due to toxicities; being replaced to some extent by safer abx like third-generation cephalosporins & floroquinolonesfrequently administered w/ PCNs to extend the spectrum (to gram-pos coverage) & take advantage of the synergism btwn these two classes of drugs 
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | pharmacodynamics of aminoglycosides |  | Definition 
 
        | inhibit protein synthesis at the level of the 30S subunit of bacterial ribosome |  | 
        |  | 
        
        | Term 
 
        | pharmacotherapeutics of aminoglycosides |  | Definition 
 
        | must useful in treating infections cased by aerobic gram-neg bacilli and serious nosocomial infections such as gram-neg bacteremia or sepsis; tx of TB   often given in combo w/ PCN to encourage facilitation of the aminoglycoside into the cell  |  | 
        |  | 
        
        | Term 
 
        | pharmacokinetics of aminoglycosides |  | Definition 
 
        | PO absorption poor so give parenterallydo not penetrate CSFexcreted unchanged by the kidneyshigh conc of these drugs tend to accumulate in the renal cortex & endolymph of the inner ear, which could account for their nephrotoxicity & ototoxicityhalf-life is 1-4 hrshave a low TI; require constant monitoring: peak (after 30 min; shows serum toxicity) and trough (30 min before next dose; shows organ toxicity) levels
 |  | 
        |  | 
        
        | Term 
 
        | contraindications with aminoglycosides |  | Definition 
 
        | no absolute contradications except in lactation  relative contraindcations are in pts with:pre-existing renal disease and/or hearing impairmentallergy to aminoglycosidesreceiving renal toxic agents (vacomycin)receving loop diuretics (Lasix)receiving an anesthetic or muscle relaxantspregnancy 
 |  | 
        |  | 
        
        | Term 
 
        | adverse effects of aminoglycosides |  | Definition 
 
        | ototoxicityrelated to high peak plasma levels& duration of tx
 has been known to affect fetuses in utero
 pts simultaneously receiving another ototoxic drug are at higher risk
 symptoms include: dizziness, tinnitus, vertigo, nystagmus, hearing loss
nephrotoxicity: 
 limited if the drugs are administered for less than 5 daysat risk: infants, elderly, pts w/ preexisting renal impairment or those receiving concurrent nephrotoxic drugskidney damage may range from mild to severe acute tubular necrosis that can be irreversible
neuromuscular paralysis: may cause respiratory paralysis; pts w/ myasthenia gravis are particularly at risk as are those receiving anesthetics or muscle relaxantsallergic reactions: contact dermatitis is a common rxn topically 
 |  | 
        |  | 
        
        | Term 
 
        | drug interactions with aminoglycosides |  | Definition 
 
        | additive renal toxic effects are noted if they are given w/ other nephrotoxic agentsloop diuretics will increased ototoxicity chancewill increase the effects of neuromuscular blocking agentssynergistic effect w/ PCNsinactivation occurs when they are mixed in the same IV sol'n w/ PCNs
 |  | 
        |  | 
        
        | Term 
 
        | nursing considerations w/ aminoglycosides |  | Definition 
 
        | promote adequate fluid intake (2L/day) to maintain adequate renal function   admin IV aminoglycosides & PCNs at least 2 hrs apart  |  | 
        |  | 
        
        | Term 
 
        | bacterial protein synthesis inhibitors:   macrolides  |  | Definition 
 
        | inhibit bacterial protein synthesis by binding to the 50S ribosomeBacteriostatic (in higher doses may be bactericidal)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | erythromycin (prototype) **comes in different preparations   azithromyxin (Zithromax)  |  | 
        |  | 
        
        | Term 
 
        | pharmacotherapeutics of macrolides |  | Definition 
 
        | erythromycin is effective against the same organisms as PCN G; use in pts allergic to PCN; drug of choice for Legionnaire's diseaseClarithromycin/azithromycin: greater gram-neg coverage; also better penetration into lung tissues & macrophages; drugs of choicein tx of mycoplasma pneumoniasubstitues for PCN to treat respiratory infections caused by streptocuccus pneumoniaeused for chlamydial infections 
 |  | 
        |  | 
        
        | Term 
 
        | contraindications of macrolides |  | Definition 
 
        | contraindicated in hypersensitivity & in pts w/ hepatic dysfunction |  | 
        |  | 
        
        | Term 
 
        | adverse effects of macrolides |  | Definition 
 
        | erythromycin is considered one of the safest abx; hypersensitivity rxns are rareGI distress: most common w/ E-mycin (21%) > clarithromycin (10%) > azithromycin (5%)superinfections
 |  | 
        |  | 
        
        | Term 
 
        | drug interactions with macrolides |  | Definition 
 
        | erythromycin & clarithromycin are metabolized by the cytochrome P-450 systemboth can reduce the clearance of many other drugs by inhibition of the CYP450 3A4 isoformAzithromycin does not undergo metabolism & does not inhibit p-450 (so, don't have to worry about other drugs here)
 |  | 
        |  | 
        
        | Term 
 
        | bacterial protein synthesis inhibitors:   lincosamine  |  | Definition 
 
        | due to its high potential for serious adverse effects, prescribed only when there is no therapeutic alternativeinhibits bacterial protein synthesisprimarily bacteriostatic; bactericidal in high doses
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | clindamycin (Cleocin)   #1topical acne drug; also prophylaxis w/ mitral valve, etc when there's PCN allergy  |  | 
        |  | 
        
        | Term 
 
        | pharmacotherapeutics of licosamine |  | Definition 
 
        | usually used to treat severe infections by anaerobic bacteria such as Bacterioides fragilis   topical preparations-acne vulgaris, affective against Propionobacterium acnes  |  | 
        |  | 
        
        | Term 
 
        | adverse effects of lincosamine |  | Definition 
 
        | Pseudomembranous colitis: destroys the normal flora which allows Clostridium difficile to grow & secrete its toxin, causing a bloody diarrhea
 |  | 
        |  | 
        
        | Term 
 
        | foliate antagonists:   sulfonamides  |  | Definition 
 
        | first effective systemic antimicrobialsdeveopment of resistant strains of bacteria & the incidence of allergic reactions to sulfa drugs resulted in their largely being relegated to tx of UTIs, OM & some STDsbacteriostatic-act b competitive inhibition of folic a cid synthesis in the microbial cells; decreased folic acid synthesis decreases the number of nucleotides & inhibits bacterial growthexhibit wide spectrum of activity against gram-pos & gram-neg bacteria
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sulfasalazine (Azulfidine) - frequent use in autoimmune conditions   mafenide (Sulfamylon)  |  | 
        |  | 
        
        | Term 
 
        | adverse effects of sulfonamides |  | Definition 
 
        | crystalluria, resulting in renal damage-older agents have low solubility 
 adequate hydration & alkalinization of urine prevent the problem by reducing the conc of drug & promoting its ionization
hypersensitivityphotosensitivityKernicterus: very high levels of bilirubin in CNSsulfa displaces bilirubin from binding sites on serum albumin; bilirubin is free to pass into the CNSsulfas should be avoided in newborns & infants less than 3 mo old a s well as pregnant women (can cause permanent brain damage) 
 |  | 
        |  | 
        
        | Term 
 
        | foliate antagonists:   sulfamethoxazole/trimethroprim  |  | Definition 
 
        | combo-greater antimicrobial activity than equivalent quantities of either drug used aloneUTIs that are caused by E.coli, Enterobacter species, Klebsiella species, etc.PCP: primary prophylaxis in clients infected w/ HIV prophylaxis (people having at least one episode of PCP)tx of acute exacerbation of chronic bronchitis and otitis media caused by H. influenza or S. pneuomniaetx of chancroid, shigelliosis, bacterial prostatitis
 |  | 
        |  |